Kiniksa Pharmaceuticals, Ltd.KNSANASDAQ
Loading
Cash & Equivalents Over TimeStrong
Percentile Rank78
3Y CAGR+10.5%
5Y CAGR+7.7%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+10.5%/yr
vs -20.5%/yr prior
5Y CAGR
+7.7%/yr
Consistent
Acceleration
+31.0pp
Accelerating
Percentile
P78
Within normal range
vs 5Y Ago
1.5x
Solid growth
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $165.60M | -9.8% |
| 2024 | $183.58M | +70.1% |
| 2023 | $107.95M | -12.0% |
| 2022 | $122.72M | +0.2% |
| 2021 | $122.47M | +7.4% |
| 2020 | $114.04M | +143.0% |
| 2019 | $46.93M | -84.7% |
| 2018 | $307.30M | +574.6% |
| 2017 | $45.55M | -18.6% |
| 2016 | $55.97M | - |